Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Gestational Diabetes Mellitus: The Impact of Carbohydrate Quality in Diet.

Filardi T, Panimolle F, Crescioli C, Lenzi A, Morano S.

Nutrients. 2019 Jul 9;11(7). pii: E1549. doi: 10.3390/nu11071549.

2.

Cardiomyopathy Associated with Diabetes: The Central Role of the Cardiomyocyte.

Filardi T, Ghinassi B, Di Baldassarre A, Tanzilli G, Morano S, Lenzi A, Basili S, Crescioli C.

Int J Mol Sci. 2019 Jul 5;20(13). pii: E3299. doi: 10.3390/ijms20133299. Review.

3.

Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study.

Solini A, Penno G, Orsi E, Bonora E, Fondelli C, Trevisan R, Vedovato M, Cavalot F, Lamacchia O, Baroni MG, Nicolucci A, Pugliese G; Renal Insufficiency And Cardiovascular Events (RIACE) Study Group.

BMC Med. 2019 Apr 25;17(1):83. doi: 10.1186/s12916-019-1313-x.

4.

Cross-talk between fetal membranes and visceral adipose tissue involves HMGB1-RAGE and VIP-VPAC2 pathways in human gestational diabetes mellitus.

Santangelo C, Filardi T, Perrone G, Mariani M, Mari E, Scazzocchio B, Masella R, Brunelli R, Lenzi A, Zicari A, Morano S.

Acta Diabetol. 2019 Jun;56(6):681-689. doi: 10.1007/s00592-019-01304-x. Epub 2019 Feb 28.

PMID:
30820673
5.

The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial.

Saglimbene V, Palmer SC, Ruospo M, Natale P, Maione A, Nicolucci A, Vecchio M, Tognoni G, Craig JC, Pellegrini F, Lucisano G, Hegbrant J, Ariano R, Lamacchia O, Sasso A, Morano S, Filardi T, De Cosmo S, Pugliese G, Procaccini DA, Gesualdo L, Palasciano G, Johnson DW, Tonelli M, Strippoli GFM; Long-Term Impact of RAS Inhibition on Cardiorenal Outcomes (LIRICO) Investigators.

J Am Soc Nephrol. 2018 Dec;29(12):2890-2899. doi: 10.1681/ASN.2018040443. Epub 2018 Nov 12.

PMID:
30420421
6.

The risk stratification of adverse neonatal outcomes in women with gestational diabetes (STRONG) study.

Pintaudi B, Fresa R, Dalfrà M, Dodesini AR, Vitacolonna E, Tumminia A, Sciacca L, Lencioni C, Marcone T, Lucisano G, Nicolucci A, Bonomo M, Napoli A; STRONG Study Collaborators.

Acta Diabetol. 2018 Dec;55(12):1261-1273. doi: 10.1007/s00592-018-1208-x. Epub 2018 Sep 17.

PMID:
30221320
7.

Linking type 2 diabetes and gynecological cancer: an introductory overview.

Anastasi E, Filardi T, Tartaglione S, Lenzi A, Angeloni A, Morano S.

Clin Chem Lab Med. 2018 Aug 28;56(9):1413-1425. doi: 10.1515/cclm-2017-0982. Review.

8.

Poly(ADP-ribosylated) proteins in mononuclear cells from patients with type 2 diabetes identified by proteomic studies.

Giorgi A, Tempera I, Napoletani G, Drovandi D, Potestà C, Martire S, Mandosi E, Filardi T, Eugenia Schininà M, Morano S, d'Erme M, Maras B.

Acta Diabetol. 2017 Sep;54(9):833-842. doi: 10.1007/s00592-017-1013-y. Epub 2017 Jun 12.

PMID:
28608282
9.

Two-hour postload glycemia is associated to an increased risk of NAFLD in healthy subjects with family history of type 2 diabetes: a case control study.

Pallotta N, Filardi T, Carnovale A, Nieddu L, Mariani P, Vincoli G, Lenzi A, Morano S.

Endocrine. 2017 Aug;57(2):352-355. doi: 10.1007/s12020-016-1008-4. Epub 2016 Jul 15. No abstract available.

PMID:
27422790
10.

Endothelial dysfunction markers as a therapeutic target for Sildenafil treatment and effects on metabolic control in type 2 diabetes.

Mandosi E, Giannetta E, Filardi T, Lococo M, Bertolini C, Fallarino M, Gianfrilli D, Venneri MA, Lenti L, Lenzi A, Morano S.

Expert Opin Ther Targets. 2015;19(12):1617-22. doi: 10.1517/14728222.2015.1066337. Epub 2015 Jul 15.

PMID:
26178526
11.

Short-term effects of glucagon-like peptide 1 (GLP-1) receptor agonists on fat distribution in patients with type 2 diabetes mellitus: an ultrasonography study.

Morano S, Romagnoli E, Filardi T, Nieddu L, Mandosi E, Fallarino M, Turinese I, Dagostino MP, Lenzi A, Carnevale V.

Acta Diabetol. 2015 Aug;52(4):727-32. doi: 10.1007/s00592-014-0710-z. Epub 2015 Jan 11.

PMID:
25577244
12.

Long-standing type 1 diabetes: patients with adult-onset develop celiac-specific immunoreactivity more frequently than patients with childhood-onset diabetes, in a disease duration-dependent manner.

Tiberti C, Panimolle F, Bonamico M, Filardi T, Pallotta L, Nenna R, Pontone S, Dotta F, Pugliese G, Lenzi A, Balducci S, Morano S.

Acta Diabetol. 2014 Aug;51(4):675-8. doi: 10.1007/s00592-013-0536-0. Epub 2014 Jan 23.

PMID:
24452477
13.

Assessment of fracture risk by the FRAX algorithm in men and women with and without type 2 diabetes mellitus: a cross-sectional study.

Carnevale V, Morano S, Fontana A, Annese MA, Fallarino M, Filardi T, Copetti M, Pellegrini F, Romagnoli E, Eller-Vainicher C, Zhukouskaya VV, Chiodini I, D'Amico G.

Diabetes Metab Res Rev. 2014 May;30(4):313-22. doi: 10.1002/dmrr.2497.

PMID:
24420974
14.

IgA anti-transglutaminase autoantibodies at type 1 diabetes onset are less frequent in adult patients and are associated with a general celiac-specific lower immune response in comparison with nondiabetic celiac patients at diagnosis.

Tiberti C, Panimolle F, Bonamico M, Shashaj B, Filardi T, Lucantoni F, Nenna R, Costantino F, Lenzi A, Morano S.

Diabetes Care. 2012 Oct;35(10):2083-5. Epub 2012 Jul 18.

Supplemental Content

Loading ...
Support Center